Guang‐Bo Ge

9.1k citations

287 papers · 7.5k indexed · 2 hit papers · h-index 48

Impact in

Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Cholinesterase and Neurodegenerative Diseases
- Pharmacological Effects of Natural Compounds
Complementary and alternative medicine top 0.5%

Papers in

Pharmacology 119
- Pharmacogenetics and Drug Metabolism 90
- Cholinesterase and Neurodegenerative Diseases 45
- Pharmacological Effects of Natural Compounds 28
- Drug-Induced Hepatotoxicity and Protection 16
Computational Theory and Mathematics 46
- Computational Drug Discovery Methods 46

Co-authors: Ling Yang Jie Hou Qiang Jin Li‐Wei Zou Lei Feng Jingnan Cui Jing NingPing Wang
Journals: International Journal of Biological Macromolecules (11 papers)Phytomedicine (10 papers)Drug Metabolism and Disposition (9 papers)RSC Advances (9 papers)Fitoterapia (9 papers)
Partner nations: China United States Finland

In The Last Decade

Guang‐Bo Ge

277 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

The SARS‐CoV‐2 main protease (M^pro): Structure, function, and emerging therapies for COVID‐19 2022 · 149 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 SHILAP Revista de lepidopterología
2018 Acta Pharmaceutica Sinica B

Peers

Countries citing papers authored by Guang‐Bo Ge

Since Specialization

Citations

This map shows the geographic impact of Guang‐Bo Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang‐Bo Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang‐Bo Ge more than expected).

Fields of papers citing papers by Guang‐Bo Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang‐Bo Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang‐Bo Ge. The network helps show where Guang‐Bo Ge may publish in the future.

Co-authors

The 25 scholars most cited alongside Guang‐Bo Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guang‐Bo Ge Line = papers co-authored together Guang‐Bo Ge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Polysaccharide Nanoadjuvants Engineered via Phenotype-Specific Nanoprobe-Assisted Phenotypic Screen Reprogram Macrophage Cell Functions for Cancer and Rheumatoid Arthritis Therapy ACS Nano ·Xuan Mo, Anping Shen, Yicun Han, Li Xu, Jiaqian Miao, Danni Xu, Qing Ji, Yuelong Cao, Guang‐Bo Ge, Xinyuan Zhu, Hongping Deng	2025	7
2	Rational engineering of isoform-specific hSULT1E1 fluorogenic substrates for functional analysis and inhibitor screening Biosensors and Bioelectronics ·Xiaoting Niu, Yufan Fan, Guanghao Zhu, Hairong Zeng, Bei Zhao, Mengru Sun, Lin Chen, Luling Wu, Zhenhao Tian, Tony D. James, Guang‐Bo Ge	2025	1
3	Polysaccharide nanoadjuvants with precise drug composition for enhanced STING-mediated APC activation European Polymer Journal ·Jingxuan Ju, Danni Xu, Li Xu, Jun Liu, Hairong Zeng, Bei Zhao, Yuan Xiong, Yuhui Ma, Guang‐Bo Ge, Hongping Deng	2024	4
4	Human UDP-glucuronosyltransferase 1As catalyze aristolochic acid D O-glucuronidation to form a lesser nephrotoxic glucuronide Journal of Ethnopharmacology ·Dong‐Zhu Tu, Peiqi Liu, Guanghao Zhu, Hairong Zeng, Yan-Yan Deng, Jian Huang, Xiao-Ting Niu, Yanfang Liu, Jing Hu, Xinmiao Liang, Moshe Finel, Ping Wang, Guang‐Bo Ge	2024	3
5	A Novel Fluorescence-Based Microplate Assay for High-Throughput Screening of hSULT1As Inhibitors Biosensors ·Xiaoting Niu, Yufan Fan, Li‐Wei Zou, Guang‐Bo Ge	2024	1
6	Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors Chemico-Biological Interactions ·Yun Yang, Yuan Xiong, Guanghao Zhu, Mengru Sun, Kun Zou, Yitian Zhao, Yong Zhang, Zhijian Xu, Yiming Li, Weiliang Zhu, Qi Jia, Bo Li, Guang‐Bo Ge	2023	9
7	An Uncertainty-Guided Deep Learning Method Facilitates Rapid Screening of CYP3A4 Inhibitors Journal of Chemical Information and Modeling ·Ruixuan Wang, Zhikang Liu, Jia-Hao Gong, Qingping Zhou, Xiao‐Qing Guan, Guang‐Bo Ge	2023	6
8	CYP1A inhibitors: Recent progress, current challenges, and future perspectives Medicinal Research Reviews ·Ziru Dai, Yue Wu, Yuan Xiong, Jingjing Wu, Min Wang, Xiao Sun, Xinxin Ding, Ling Yang, (unknown), (unknown), Guang‐Bo Ge	2023	16
9	GeoDILI: A Robust and Interpretable Model for Drug-Induced Liver Injury Prediction Using Graph Neural Network-Based Molecular Geometric Representation Chemical Research in Toxicology ·Wenxuan Wu, J.P. Qian, Changjie Liang, Jingya Yang, Guang‐Bo Ge, Qingping Zhou, Xiao‐Qing Guan	2023	8
10	Super-Resolution Imaging of Autophagy by a Preferred Pair of Self-Labeling Protein Tags and Fluorescent Ligands Analytical Chemistry ·Huizi Man, Lin Zhou, Guanghao Zhu, Ying Zheng, Zhiwei Ye, Zhenlong Huang, Xinru Teng, Chun‐Zhi Ai, Guang‐Bo Ge, Yi Xiao	2022	4
11	Rational design and development of a novel and highly specific near-infrared fluorogenic substrate for sensing and imaging of human pancreatic lipase in living systems Sensors and Actuators B Chemical ·Qing Hu, Zhenhao Tian, Haonan Wang, Jian Huang, Fangyuan Wang, Bei Zhao, Rong-Jing He, Qiang Jin, Xu-Dong Hou, Jie Hou, Sheng-Quan Fang, Ping Wang, Guang‐Bo Ge	2021	30
12	Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines RSC Advances ·Dongfang Zhao, Yufan Fan, Fangyuan Wang, Fan-Bin Hou, Frank J. Gonzalez, Shi-Yang Li, Ping Wang, Yangliu Xia, Guang‐Bo Ge, Ling Yang	2021	13
13	Design, synthesis and biological evaluation of indanone–chalcone hybrids as potent and selective hCES2A inhibitors European Journal of Medicinal Chemistry ·Peng-Chao Huo, Xiao‐Qing Guan, Peng Liu, Yun‐Qing Song, Mengru Sun, Rong-Jing He, Li‐Wei Zou, Xue Li-juan, Jinhui Shi, Nan Zhang, Zhiguo Liu, Guang‐Bo Ge	2020	23
14	Target Enzyme‐Activated Two‐Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two‐Dimensional Design Strategy Angewandte Chemie ·Jing Ning, Wei Wang, Guang‐Bo Ge, Peng Chu, Feida Long, Yongliang Yang, Yulin Peng, Lei Feng, Xiaochi Ma, Tony D. James	2019	10
15	Target Enzyme‐Activated Two‐Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two‐Dimensional Design Strategy Angewandte Chemie International Edition ·Jing Ning, Wei Wang, Guang‐Bo Ge, Peng Chu, Feida Long, Yongliang Yang, Yulin Peng, Lei Feng, Xiaochi Ma, Tony D. James	2019	84
16	Carboxylesterases mediated herb-drug interactions: a systematic review Dandan Wang, Yun‐Qing Song, Yi Zhu, Yinan Wang, Haifeng Li, Guang‐Bo Ge, Ling Yang	2019	3
17	Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2 Journal of the American Chemical Society ·Jing Ning, Tao Liu, Peipei Dong, Wei Wang, Guang‐Bo Ge, Bo Wang, Zhenlong Yu, Lei Shi, Xiangge Tian, Xiaokui Huo, Lei Feng, Chao Wang, Cheng‐Peng Sun, Jingnan Cui, Tony D. James, Xiaochi Ma	2018	152
18	N ‐Butyl‐4‐hydroxy‐1,8‐naphthalimide: A new matrix for small molecule analysis by matrix‐assisted laser desorption/ionization mass spectrometry Rapid Communications in Mass Spectrometry ·Xina Cheng, Xueting Ye, Dan Liu, Nan Zhao, Huiyuan Gao, Ping Wang, Guang‐Bo Ge, Xiaozhe Zhang	2017	5
19	An Optimized Two‐Photon Fluorescent Probe for Biological Sensing and Imaging of Catechol‐O‐Methyltransferase Chemistry - A European Journal ·Ping Wang, Yangliu Xia, Li‐Wei Zou, Xing‐Kai Qian, Tongyi Dou, Qiang Jin, S. S. Li, Yang Yu, Dandan Wang, Qun Luo, Guang‐Bo Ge, Ling Yang	2017	43
20	UGT1A10 Is a High Activity and Important Extrahepatic Enzyme: Why Has Its Role in Intestinal Glucuronidation Been Frequently Underestimated? Molecular Pharmaceutics ·Johanna Troberg, Erkka Järvinen, Guang‐Bo Ge, Ling Yang, Moshe Finel	2016	24

About Guang‐Bo Ge

Guang‐Bo Ge is a scholar working on Pharmacology, Pharmacology, Computational Theory and Mathematics, Complementary and alternative medicine and Oncology, having authored 287 papers that have together received 7.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (90 papers), Computational Drug Discovery Methods (46 papers), Cholinesterase and Neurodegenerative Diseases (45 papers), Drug Transport and Resistance Mechanisms (37 papers), Pharmacological Effects of Natural Compounds (28 papers), Cancer therapeutics and mechanisms (19 papers), Drug-Induced Hepatotoxicity and Protection (16 papers) and Electrochemical sensors and biosensors (13 papers). The work is most often cited by research in Pharmacology (2.0k citations), Pharmacology (1.7k citations), Complementary and alternative medicine (563 citations), Biochemistry (470 citations) and Computational Theory and Mathematics (991 citations). Guang‐Bo Ge has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Ling Yang, Jie Hou, Qiang Jin, Li‐Wei Zou, Lei Feng, Jingnan Cui, Jing Ning, Ping Wang, Jie Hou and Yun‐Feng Cao. Their work appears in journals such as International Journal of Biological Macromolecules, Phytomedicine, Drug Metabolism and Disposition, RSC Advances and Fitoterapia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact